NASDAQ:CTKB | Profit Breakdown | Cytek Biosciences, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30$48.14M$28.34M-$11.4M-$12.16M
2026-03-31$44.14M$21.25M-$18.46M-$18.87M
2025-12-31$62.14M$32.89M-$5.59M-$4.03M-$44.08M
2025-09-30$52.29M$27.55M-$9.19M-$7.77M-$5.48M
2025-06-30$45.6M$23.87M-$10.62M-$6.78M-$5.58M
2025-03-31$41.46M$20.16M-$14.98M-$11.27M-$11.4M
2024-12-31$57.48M$33.65M$2.99M$10.32M$9.64M
2024-09-30$51.5M$29.01M-$4.25M$157,000.00$941,000.00
2024-06-30$46.62M$25.44M-$8.53M-$7.19M-$10.43M
2024-03-31$44.86M$23.01M-$10.73M-$8.99M-$6.17M
2023-12-31$58.23M$33.05M-$137,000.00$4.11M$5.5M
2023-09-30$48M$27.18M-$6.42M-$4.19M-$6.46M
2023-06-30$49.69M$28.16M-$9.13M-$6.6M-$4.39M
2023-03-31$37.09M$21.04M-$12.16M-$9.04M-$6.81M
2022-12-31$48.34M$29.37M$84,000.00$4.11M$3.72M
2022-09-30$40.48M$26.86M$1.36M$1.85M$1.63M
2022-06-30$40.16M$24.56M-$891,000.00-$1.4M-$702,000.00
2022-03-31$35.06M$20.18M-$2.36M-$3.3M-$2.16M
2021-12-31$38.89M$23.64M$1.32M$444,000.00-$1.17M
2021-09-30$34.38M$21.28M$2.9M$2.08M$1.42M
2021-06-30$30.41M$19.75M$3.81M$3.27M$2.67M
2021-03-31$24.27M$14.49M$1.13M$152,000.00$102,000.00
2020-12-31$30.62M$19.45M$7.88M$8M$5.6M
2020-09-30$25.1M$15.62M$6.71M$6.9M$6.54M
2020-06-30$19.14M$8.27M-$218,000.00$192,000.00$8.11M
2020-03-31-$839,000.00

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$201.49M$104.46M-$40.38M-$29.84M-$66.54M
2024-12-31$200.45M$111.11M-$20.52M-$5.7M-$6.02M
2023-12-31$193.02M$109.43M-$27.85M-$15.71M-$12.15M
2022-12-31$164.04M$100.97M-$1.8M$1.26M$2.48M
2021-12-31$127.95M$79.14M$9.16M$5.94M$3.03M
2020-12-31$92.84M$51.71M$13.66M$14.43M$19.41M